This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Wellinghausen, N.
Right arrow Articles by Sakka, S. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wellinghausen, N.
Right arrow Articles by Sakka, S. G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2009, p. 2759-2765, Vol. 47, No. 9
0095-1137/09/$08.00+0     doi:10.1128/JCM.00567-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Diagnosis of Bacteremia in Whole-Blood Samples by Use of a Commercial Universal 16S rRNA Gene-Based PCR and Sequence Analysis{triangledown}

Nele Wellinghausen,1 Anna-Julia Kochem,2 Claudia Disqué,3 Helge Mühl,3 Susanne Gebert,1 Juliane Winter,1 Jens Matten,4 and Samir G. Sakka2*

Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, D-89081 Ulm, Germany, and Dr. Gaertner & Partner Laboratories, Ravensburg, Germany,1 Kliniken der Stadt Köln gGmbH, Krankenhaus Merheim, Ostmerheimerstrasse 200, D-51109 Cologne, Germany,2 Hochschule Bremerhaven, Institut für Angewandte Mikrobiologie und Biotechnologie, An der Karlstadt 8, D-27568 Bremerhaven, Germany,3 MVZ Leverkusen, Abteilung Medizinische Mikrobiologie, Ostmerheimerstrasse 200, 51109 Cologne, Germany4

Received 19 March 2009/ Returned for modification 24 April 2009/ Accepted 22 June 2009

In a prospective, multicenter study of 342 blood samples from 187 patients with systemic inflammatory response syndrome, sepsis, or neutropenic fever, a new commercial PCR test (SepsiTest; Molzym) was evaluated for rapid diagnosis of bacteremia. The test comprises a universal PCR from the 16S rRNA gene, with subsequent identification of bacteria from positive samples by sequence analysis of amplicons. Compared to blood culture (BC), the diagnostic sensitivity and specificity of the PCR were 87.0 and 85.8%, respectively. Considering the 34 BC-positive patients, 28 were also PCR positive in at least one of the samples, resulting in a patient-related sensitivity of 82.4%. The concordance of PCR and BC for both positive and negative samples was (47 + 247)/342, i.e., 86.0%. In total, 31 patients were PCR/sequencing positive and BC negative, in whom the PCR result was judged as possible or probable to true bacteremia in 25. In conclusion, the PCR approach facilitates the detection of bacteremia in blood samples within a few hours. Despite the indispensability of BC diagnostics, the rapid detection of bacteria by SepsiTest appears to be a valuable tool, allowing earlier pathogen-adapted antimicrobial therapy in critically ill patients.

* Corresponding author. Mailing address: Klinik für Anästhesiologie und Operative Intensivmedizin, Lehrstuhl II, Universität Witten/Herdecke, Kliniken der Stadt Köln gGmbH, Krankenhaus Merheim, Ostmerheimerstr. 200, D-51109 Cologne, Germany. Phone: 49-221-8907-3863. Fax: 49-221-8907-8666. E-mail: sakkas{at}kliniken-koeln.de

{triangledown} Published ahead of print on 1 July 2009.

Journal of Clinical Microbiology, September 2009, p. 2759-2765, Vol. 47, No. 9
0095-1137/09/$08.00+0     doi:10.1128/JCM.00567-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»